Parenteral third-generation cephalosporins have a broad spectrum of ac
tivity against a wide variety of pathogens. Cefotaxime and ceftriaxone
sodium have become drugs of choice for the empirical treatment of men
ingitis in infants, children, and adults. The role of these extended-s
pectrum cephalosporins for serious infections in pediatric patients is
expanding.